Related Experiment Video
Updated: May 8, 2026
10:16
Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
GHB, GBL and 1,4-BD addiction
Tibor M Brunt, Jan G C van Amsterdam, Wim van den Brink1
1Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Da Costakade 45, 3521 VS Utrecht, The Netherlands. TBrunt@trimbos.nl.
Current Pharmaceutical Design
|September 5, 2013
Summary
Gamma-hydroxybutyric acid (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are highly addictive substances. Detoxification with pharmaceutical GHB is effective, but relapse prevention requires further research.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Gamma-hydroxybutyric acid (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are increasingly recognized as addictive substances.
- Problematic use of GHB is reportedly rising in the European Union, necessitating a comprehensive review of current knowledge.
Purpose of the Study:
- To review the existing literature on the neurochemistry, toxicity, addiction potential, and withdrawal of GHB and its precursors.
- To investigate the molecular mechanisms of addiction and evaluate current treatment strategies for withdrawal and addiction.
Main Methods:
- Systematic literature review of scientific articles and studies.
- Analysis of neurochemical, toxicological, and clinical data on GHB, GBL, and 1,4-BD.
Main Results:
- GHB and its precursors exhibit high addictive potential in humans and animals, likely mediated by GABAB receptors.
- Withdrawal symptoms can be severe and medically urgent. Benzodiazepines show limited efficacy, while pharmaceutical GHB-assisted detoxification has proven successful.
- Relapse rates are high, indicating a need for improved relapse prevention strategies.
Conclusions:
- GHB, GBL, and 1,4-BD pose significant addiction risks, with severe withdrawal requiring specialized medical attention.
- Current treatment paradigms show promise with pharmaceutical GHB, but long-term management and relapse prevention require further investigation.
- Enhanced understanding and practitioner guidance are crucial for addressing the growing challenge of GHB-related substance use disorders.
More Related Videos
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...